The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Aminopyridazine ID: ALA5170155
Cas Number: 5469-70-5
PubChem CID: 230373
Product Number: A123467, Order Now?
Max Phase: Preclinical
Molecular Formula: C4H5N3
Molecular Weight: 95.11
Associated Items:
Names and Identifiers Canonical SMILES: Nc1cccnn1
Standard InChI: InChI=1S/C4H5N3/c5-4-2-1-3-6-7-4/h1-3H,(H2,5,7)
Standard InChI Key: LETVJWLLIMJADE-UHFFFAOYSA-N
Molfile:
RDKit 2D
7 7 0 0 0 0 0 0 0 0999 V2000
-0.7133 -0.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0013 0.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7133 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7133 -0.8253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 -1.2371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7133 -0.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0013 1.2371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
5 4 2 0
1 6 2 0
6 5 1 0
2 7 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 95.11Molecular Weight (Monoisotopic): 95.0483AlogP: 0.06#Rotatable Bonds: ┄Polar Surface Area: 51.80Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.41CX LogP: -0.46CX LogD: -0.46Aromatic Rings: 1Heavy Atoms: 7QED Weighted: 0.50Np Likeness Score: -1.13
References 1. Wu Q, Sun Z, Chen Z, Liu J, Ding H, Luo C, Wang M, Du D.. (2022) The discovery of a non-competitive GOT1 inhibitor, hydralazine hydrochloride, via a coupling reaction-based high-throughput screening assay., 73 [PMID:35820623 ] [10.1016/j.bmcl.2022.128883 ]